Company Filing History:
Years Active: 2016-2018
Title: Kim Vilbour Andersen: Innovator in MIC-1 Fusion Proteins
Introduction
Kim Vilbour Andersen is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of MIC-1 fusion proteins. With a total of two patents to his name, Andersen's work has implications for pharmaceutical applications.
Latest Patents
Andersen's latest patents focus on MIC-1 fusion proteins and their uses. The invention relates to compounds that comprise fusion proteins featuring a MIC-1 protein or an analog at the C-terminus, along with a functional variant of human serum albumin at the N-terminus. These components are connected via a peptide linker, resulting in compounds that exhibit MIC-1 activity. Additionally, the invention encompasses pharmaceutical compositions that include these compounds and pharmaceutically acceptable excipients, as well as their medical applications.
Career Highlights
Kim Vilbour Andersen is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to focus on innovative solutions in the biotechnology sector, contributing to advancements in medical treatments.
Collaborations
Andersen has collaborated with notable colleagues, including Allan Christian Shaw and Charlotte Helgstrand. These partnerships have fostered a collaborative environment that enhances the research and development of innovative biopharmaceuticals.
Conclusion
Kim Vilbour Andersen's contributions to the field of biotechnology, particularly through his patents on MIC-1 fusion proteins, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical applications and pharmaceutical compositions.